EmboCept S® is a microsphere based medical device used in vascular occlusion of liver and lung tumours and is marketed by PharmaCept.
SmartGel is a non-allergenic hydrogel based on our unique microsphere technology. It contains PHMB incorporated into fully biodegradable starch microspheres, which are suspended in a gel matrix for optimal infection prevention and treatment. The gel delivers moisture to the wound, whilst maintaining enough absorption capacity for exudate, debris and bacteria and is currently marketed by AXXO.
SmartPan is a first in class product for the detection of pancreatic fluid leakage during surgical procedures. SmartPan is currently under review by a European Notified Body for registration in Europe.
Pipeline: We have a rich pipeline of future projects based on our technology, some of our current projects include:
EmboCept M® for the treatment of benign prostatic hyperplasia.
EmboCept L® for the treatment of uterine fibroids.
SmartGel II an advanced wound care hydrogel highly effective in the removal and prevention of wound biofilm.
SmartBone an advanced formulation of microspheres in combination with active ingredients for stimulation of bone growth in surgical implant procedures.
Contact us to become a distributor for our products.